Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase ...

Immuneering Corporation (IMRX), a clinical-stage oncology company, Thursday said it has signed a clinical supply agreement with ...

CAMBRIDGE, Mass. - Immuneering Corporation (NASDAQ:IMRX), a clinical-stage oncology company with a market capitalization of $59.31 million, has entered into a clinical supply agreement with Regeneron ...

Shares of Regeneron Pharmaceuticals have plunged more than 30% over the past six months, but one Wall Street analyst believes ...

Radioavisen 31.01.2025 kl. 12.10 ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...

LEXINGTON, Mass., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company ...

If you purchase a product or register for an account through a link on our site, we may receive compensation. By using this site, you consent to our User Agreement and agree that your clicks ...

2-Year U.S. Treasury Note Continuous Contract $102.766 0.008 0.01% 5-Year U.S. Treasury Note Continuous Contract $106.320-0.070-0.07% 10-Year U.S. Treasury Note Continuous Contract $108.781-0.172 ...

Spb 1 Boligkredi As 24/perp Adj C Hybrid is listed on the Euronext Oslo trading with ticker code SPBKR104-PRO.OL. It has a market capitalisation of -, with approximately 4.00k shares in issue.

Pete is joined by his final choice as part of Radio 1 Dance's Future Stars, Deer Jade. FKA Twigs enters Album Mode, and Richard Russell picks his 3.